Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

dermal absorption in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2004-11-15 to 2004-11-25
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline study, to GLP

Data source

Referenceopen allclose all

Reference Type:
study report
Report date:
Reference Type:
secondary source

Materials and methods

Test guideline
according to guideline
OECD Guideline 428 (Skin Absorption: In Vitro Method)
GLP compliance:

Test material

Constituent 1
Chemical structure
Reference substance name:
Alkanes, C14-17, chloro
EC Number:
EC Name:
Alkanes, C14-17, chloro
Cas Number:
Molecular formula:
Substance is a range of chlorinated isomers of C14 to C17 paraffin
Alkanes, C14-17, chloro
Details on test material:
- Name of test material (as cited in study report): Cereclor S52
- Substance type: technical product
- Physical state: colourless liquid
- Analytical purity: >99.9%
- Impurities (identity and concentrations): no data concerning presence/absence of stabiliser
- Composition of test material, percentage of components: C14-17 chlorinated paraffin (52% chlorination).
- Purity test date: no data
- Lot/batch No.: CD9327
- Expiration date of the lot/batch: July 2005
- Radiochemical purity (if radiolabelling): >98%
- Specific activity (if radiolabelling): 39.22 MBq/g (49.34 MBq/ml; 1.33 mCi/ml)
- Locations of the label (if radiolabelling): [8-14C]C14-17 chlorinated paraffin (52% chlorination)
- Expiration date of radiochemical substance (if radiolabelling): no data
- Stability under test conditions: no data
- Storage condition of test material: ambient conditions in the dark (unlabelled) ; refrigerated (labelled)

Test animals

not specified
Details on test animals or test system and environmental conditions:
Not relevant

Administration / exposure

Type of coverage:
other: occluded and unoccluded
unchanged (no vehicle)
Duration of exposure:
24 hours
- Actual doses: 12.6 and 125.8 mg/cm2- Actual doses calculated as follows: volume x specific gravity- Dose volume: 10 and 100 µl/cm2- Rationale for dose selection: "to simulate predicted possible and maximal human exposure"
No. of animals per group:
not relevant
Control animals:
Details on study design:
2 epidermal membranes from each of 3 subjects used in studyAt recorded intervals (2, 4, 8, 12, 16, 20 & 24 h), 0.5 ml samples of the receptor fluid were taken for analysis by liquid scintillation counting (LSC).Residual activity on membrane surface was removed by washing off with sponges soaked in 3% Teepol detergent (first wash) followed by water. Radioactivity recovered was determined by LSC.Dermal penetration was determined by stripping dried membrane with adhesive tape (max. 5 strips) and analysing by LSC.Residual activity on membrane determined by LSC.
Details on in vitro test system (if applicable):
SKIN PREPARATION- Source of skin: human (surgery or post mortem)- Ethical approval if human skin: no data- Type of skin: epidermal membrane- Preparative technique: warm (60oC) water- Thickness of skin (in mm): no data- Membrane integrity check: yes - electrical resistance >10 kohms- Storage conditions: no data- Justification of species, anatomical site and preparative technique: PRINCIPLES OF ASSAY- Diffusion cell: yes- Receptor fluid: 6% Polyoxyethylene 20 oleyl ether (Volpo N20) in water- Solubility of test substance in receptor fluid: 1.85 mg/ml- Static system: yes; receptor fluid stirred continuously- Flow-through system: no- Test temperature: 32oC- Humidity: no data- Occlusion: occluded and non-occluded- Reference substance(s): no

Results and discussion

Signs and symptoms of toxicity:
not specified
Dermal irritation:
not specified
Absorption in different matrices:
Unoccluded:- Skin wash: 99.1%- Receptor fluid, receptor chamber, donor chamber (in vitro test system): receptor fluid 0.002% ; donor chamber 0.16%- Skin preparation (in vitro test system): residual membrane after stripping 0.70%- Stratum corneum (in vitro test system): (i.e tape strips) 2.15%
Total recovery:
Mean recovery for 6 membranes - 102%
Percutaneous absorption
12.6 mg/cm2
ca. 0.7 %
Remarks on result:
other: 24 hours
unoccluded; Cereclor S52
Conversion factor human vs. animal skin:
Not applicable

Any other information on results incl. tables

The absorption rate for the unoccluded application was 0.01 µg/cm2/h, equivalent to an absorption of 0.243 µg/cm2 or 0.002% of the dose. The corresponding values for the occluded application were 0.057 µg/cm2/h, equivalent to an absorption of 1.367 µg/cm2 or 0.001% of the dose.

Applicant's summary and conclusion

In a study to investigate the likely absorption of Cereclor S52 (a C14-17 chlorinated paraffin; 52% chlorination) through human epidermis under the most conservative conditions (epidermal membrane, solubilising receptor fluid, prolonged exposure), the maximum dermal absorption was determined to be approximately 0.7%.
Executive summary:

The in vitro absorption and distribution of Cereclor S52, a C14-17 chlorinated paraffin (52% chlorination), through human epidermis has been determined using 14C-labelled test material in a static cell system with a stirred solubilising receptor phase. The distribution of radiolabel within the test system (skin wash, donor chamber, stratum corneum and residual epidermal tissue) following 24 h exposure to an unoccluded 10 μl/cm² dose and an occluded 100 μl/cm² dose was determined. This study was performed according to OECD guidelines 428, and to GLP.

The mean overall recovery of the (unoccluded) 10 µl/cm2 dose (about 12.6 mg/cm2) was 102% of the applied dose recovered. The vast majority of the applied dose (mean 99.1%) was washed off the skin, with only a small proportion recovered from the stratum corneum (2.15%) and the remaining epidermis (0.702%). The absorption through the epidermis was very slow, with an absorption rate of 0.01 μg/cm²/h during the 24 h (unoccluded) exposure period. The amount absorbed over 24 h was therefore 0.243 μg/cm2 (0.002% of the dose).

The absorption of Cereclor S52 from a 100 μl/cm² occluded dose (about 126 mg/cm2) through human epidermis was also very slow, with an absorption rate of 0.057μg/cm²/h during the 24 h exposure period. The amount absorbed over 24 h was 1.367 μg/cm2 (0.001% of the dose).

The overall skin absorption of Cereclor S52 determined by this study (0.7%) is likely to be an overestimate, as the study was designed to measure skin penetration through human epidermis under the most conservative conditions.